RT Journal Article
SR Electronic
T1 SARS-CoV-2 Protein in Wastewater Mirrors COVID-19 Prevalence
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.09.01.20185280
DO 10.1101/2020.09.01.20185280
A1 Nafisa Neault
A1 Aiman Tariq Baig
A1 Tyson E. Graber
A1 Patrick M. D’Aoust
A1 Elisabeth Mercier
A1 Ilya Alexandrov
A1 Daniel Crosby
A1 Stephen Baird
A1 Janice Mayne
A1 Thomas Pounds
A1 Malcolm MacKenzie
A1 Daniel Figeys
A1 Alex MacKenzie
A1 Robert Delatolla
YR 2020
UL http://medrxiv.org/content/early/2020/09/03/2020.09.01.20185280.abstract
AB The COVID-19 pandemic has given rise to diverse approaches to track infections. The causative agent, SARS-CoV-2, is a fecally-shed RNA virus, and many groups have assayed wastewater for viral RNA fragments by quantitative reverse transcription polymerase chain reaction (qRT-PCR) as a proxy for COVID-19 prevalence in the community. Most groups report low levels of viral RNA that often skirt the method’s theoretical limits of detection and quantitation. Here, we demonstrate the presence of SARS-CoV-2 structural proteins in wastewater using traditional immunoblotting and quantitate them from wastewater solids using an immuno-linked PCR method called Multiplex Paired-antibody Amplified Detection (MPAD). MPAD demonstrated facile detection of SARS-CoV-2 proteins compared with SARS-CoV-2 RNA via qRT-PCR in wastewater. In this longitudinal study, we corrected for stochastic variability inherent to wastewater-based epidemiology using multiple fecal content protein biomarkers. These normalized SARS-CoV-2 protein data correlated well with public health metrics. Our method of assaying SARS-CoV-2 protein from wastewater represents a promising and sensitive epidemiological tool to assess prevalence of fecally-shed pathogens in the community.Competing Interest StatementThe authors have declared no competing interest.Funding Statement"Measurement of SARS-CoV-2 Protein and RNA in Wastewater Real-Time Measurement of Community Viral Load" (IFPOC Project#: CHA-20-012) Innovation Fund Provincial Oversight Committee Childrens Hospital Academic Medical Organization Natural Sciences and Engineering Research Council (Discovery)Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:N/AAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData is available from the authors.